BusinessImmuron to Present at RedChip’s Global Online Growth ConferenceBy Nasdaq OMXDec 6, 2017, 2:04 PM UTC
BusinessVan Leeuwenhoeck Institute Updates Immuron Research CoverageBy Nasdaq OMXNov 22, 2017, 2:00 PM UTC
BusinessImmuron Successfully Completes NASH Phase II Clinical Study MilestoneBy Nasdaq OMXNov 9, 2017, 2:01 PM UTC
BusinessImmuron Commences US Non-Deal Institutional Investor RoadshowBy Nasdaq OMXAug 15, 2017, 1:15 PM UTC
BusinessImmuron Approved to Commence Clinical Study in C.Difficile Infection (CDI)By Nasdaq OMXAug 9, 2017, 12:30 PM UTC
